Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Arjo AB's gross profit for the
three
months ended in Jun. 2026 was $122 Mil. Arjo AB's gross profit for the trailing twelve months (TTM) ended in Jun. 2026 was $489 Mil.
Gross Margin % is calculated as gross profit divided by its revenue. Arjo AB's gross profit for the
three
months ended in Jun. 2026 was $122 Mil. Arjo AB's Revenue for the
three
months ended in Jun. 2026 was $290 Mil. Therefore, Arjo AB's Gross Margin % for the quarter that ended in Jun. 2026 was 42.15%.
Arjo AB had a gross margin of 42.15% for the quarter that ended in Jun. 2026 => Durable competitive advantage
During the past 13 years, the highestGross Margin % of Arjo AB was 46.41%. The lowest was 41.91%. And the median was 43.97%.
Warning Sign:
Arjo AB gross margin has been in long-term decline. The average rate of decline per year is -1.4%.
Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.
Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %
1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key
Arjo AB had a gross margin of 42.15% for the quarter that ended in Jun. 2026 => Durable competitive advantage
Arjo AB Gross Profit Related Terms
Arjo AB Gross Profit Historical Data
* Premium members only.
The historical data trend for Arjo AB's Gross Profit can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Distribution subindustry, Arjo AB's Gross Profit, along with its competitors' market caps and Gross Profit data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Arjo AB Gross Profit vs Medical Distribution Industry
For the Medical Distribution industry and Healthcare sector, Arjo AB's Gross Profit distribution charts can be found below:
* The bar in red indicates where Arjo AB's Gross Profit falls into.
Gross Profit for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $489 Mil.
Gross Profit is the numerator in the calculation of Gross Margin.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.
Arjo AB (ARRJF) has a Gross Profit of $489 Mil as of Jun. 2026. Gross Profit equals net sales less total cost of goods sold. View historical data on Arjo AB and its competitors.
Is Arjo AB's Gross Profit too high?
Arjo AB's current Gross Profit is $489 Mil. Overall, Arjo AB has a GF Score™ of 74/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Arjo AB's Gross Profit compare to MCK and COR?
Arjo AB's Gross Profit of $489 Mil can be compared against companies in the Medical Distribution industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Gross Profit for a Medical Distribution company?
A good Gross Profit depends on the Medical Distribution industry context. However, Gross Profit should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Gross Profit mean?
A high Gross Profit can signal that a stock is expensive relative to its fundamentals. Gross Profit equals net sales less total cost of goods sold. View historical data on Arjo AB and its competitors. Arjo AB's current Gross Profit is $489 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Arjo AB stock overvalued right now?
Based on GuruFocus' analysis, Arjo AB (ARRJF) is currently considered Modestly Undervalued. The stock's GF Value™ is $3.53, compared to a current price of $2.85 — trading 19.3% below its estimated fair value. The current Gross Profit is $489 Mil. Arjo AB's overall GF Score™ is 74/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Gross Profit calculated?
Gross Profit is calculated from a company's financial statements. For Arjo AB (ARRJF), the current Gross Profit is $489 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Arjo AB (ARRJF) Overvalued in 2026?
Based on GuruFocus' analysis, Arjo AB stock appears to be undervalued.
The current stock price of $2.85 is trading 19.3% below its estimated GF Value™ of $3.53.
GuruFocus considers Arjo AB to be Modestly Undervalued.
Key valuation signals for ARRJF:
Gross Profit: $489 Mil
GF Value™: $3.53 vs. price of $2.85 (19.3% below fair value)
No single metric tells the full story. See the ARRJF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Arjo AB is a supplier of medical devices, services, and solutions in Sweden. It serves its services to private and public institutions with acute care and long-term care. The company's offering includes products and solutions for patient handling, hygiene, disinfection, medical beds, therapeutic surfaces, venous thromboembolism (VTE) prevention and diagnostics. The company includes segments: Global Sales, North America, Diagnostics.
74GF Score
Get the complete analysis for ARRJF
Gross Profit is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ARRJF has been successfully added to your 
